Director, PRESIDENT AND CEO · Cytek Biosciences, Inc. · Common Stock
Side
F
Value
$13K
Shares
2,869
Price
$4.67
Executed
Aug 18, 2026
Disclosed
Aug 20, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 18 executedAug 20, 2026 disclosed
CTKB · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$13K reported value · 0.1% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Jiang Wenbin filed this Form 4 reporting a tax withholding of CTKB on Aug 18, 2026. It became public on Aug 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, PRESIDENT AND CEO
Jiang Wenbincik:0001872873
Issuer
Cytek Biosciences, Inc.cik:0001831915
Revision history · 0
No field has changed since this record was first ingested.
